Insider · CIK 0002012250
Victoria Ninon Olivia Niklas
Files at FBLG (FibroBiologics, Inc.). First filing -, latest -.
Victoria Ninon Olivia Niklas files SEC Form 4 as director at FBLG (FibroBiologics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Victoria Ninon Olivia Niklas has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,803 | $0.00 | $0 | 30,803 | Jun 23, 2026 |
| Jun 12, 2025 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jun 12, 2025 |
Questions about Victoria Ninon Olivia Niklas
Answered from the filings on this page, as of the latest one.
Is Victoria Ninon Olivia Niklas buying or selling?
Victoria Ninon Olivia Niklas has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Victoria Ninon Olivia Niklas's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Victoria Ninon Olivia Niklas has 0.
Where does Victoria Ninon Olivia Niklas file Form 4?
Victoria Ninon Olivia Niklas has filed Form 4 at FBLG (FibroBiologics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.